Cited by 126Sleep and related disordersCircadian rhythm and melatoninMagnesium in Health and Disease

The effect of melatonin, magnesium, and zinc on primary insomnia in long-term care facility residents in Italy: A double-blind, placebo-controlled clinical trial

Rondanelli, Mariangela, Opizzi, Annalisa, Monteferrario, Francesca, Antoniello, Neldo, Manni, Raffaele, Klersy, Catherine·2011·Journal of the American Geriatrics Society

Abstract

OBJECTIVES: To determine whether nightly administration of melatonin, magnesium, and zinc improves primary insomnia in long-term care facility residents. DESIGN: Double-blind, placebo-controlled clinical trial. SETTING: One long-term care facility in Pavia, Italy. PARTICIPANTS: Forty-three participants with primary insomnia (22 in the supplemented group, 21 in the placebo group) aged 78.3 ± 3.9. INTERVENTION: Participants took a food supplement (5 mg melatonin, 225 mg magnesium, and 11.25 mg zinc, mixed with 100 g of pear pulp) or placebo (100 g pear pulp) every day for 8 weeks, 1 hour before bedtime. MEASUREMENTS: The primary goal was to evaluate sleep quality using the Pittsburgh Sleep Quality Index. The Epworth Sleepiness Scale, the Leeds Sleep Evaluation Questionnaire (LSEQ), the Short Insomnia Questionnaire (SDQ), and a validated quality-of-life instrument (Medical Outcomes Study 36-item Short Form Survey (SF-36)) were administered as secondary end points. Total sleep time was evaluated using a wearable armband-shaped sensor. All measures were performed at baseline and after 60 days. RESULTS: The food supplement resulted in considerably better overall PSQI scores than placebo (difference between groups in change from baseline PSQI score=6.8; 95% confidence interval=5.4-8.3, P<.001). Moreover, the significant improvements in all four domains of the LSEQ (ease of getting to sleep, P<.001; quality of sleep, P<.001; hangover on awakening from sleep, P=.005; alertness and behavioral integrity the following morning, P=.001), in SDQ score (P<.001), in total sleep time (P<.001), and in SF-36 physical score (P=.006) suggest that treatment had a beneficial effect on the restorative value of sleep. CONCLUSION: The administration of nightly melatonin, magnesium, and zinc appears to improve the quality of sleep and the quality of life in long-term care facility residents with primary insomnia.

Integrity signals

Registry

Crossref · 10.1111/j.1532-5415.2010.03232.x

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A food-based supplement containing 5 mg melatonin, 225 mg magnesium, and 11.25 mg zinc significantly improved subjective sleep quality scores and total sleep duration in older adults (n = 43).

    “A placebo controlled double blind study on older adults (n = 43), demonstrated a food based supplement containing 5 mg melatonin, 225 mg magnesium and 11.25 mg zinc, significantly (p < 0.001) improved subjective sleep quality scores in the intervention group but not the controls (difference between the groups 6.8; 95% CI 5.4–8.3) and total sleep duration (182.18 min; 95% CI 160.02–204.34) assessed”

    From Sleep and Nutrition Interactions: Implications for Athletes (2019) · cites this paper as [75]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Rondanelli, M., Opizzi, A., Monteferrario, F., Antoniello, N., Manni, R., & Klersy, C.
Affiliations
University of Pavia (IT)
Venue
Journal of the American Geriatrics Society
Publisher
Wiley
Published
2011-01
Volume
59
Issue
1
Pages
82-90
ISSN
  • 0002-8614 (ISSN-L)
  • 1532-5415
OpenAlex
W2127276935
Cited by
126
References
52
Citations by year
2026: 4 · 2025: 11 · 2024: 14 · 2023: 12 · 2022: 5 · 2021: 9 · 2020: 11 · 2019: 8 · 2018: 7 · 2017: 11 · 2016: 2 · 2015: 7 · 2014: 7 · 2013: 8 · 2012: 6
FWCI
9.92
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of the American Geriatrics Society (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
  • Health Sciences › Nursing › Nutrition and Dietetics › Magnesium in Health and Disease
Keywords
primary insomnia, melatonin, magnesium, zinc, dietary supplementation, long-term care residents, sleep quality, quality of life, older adults, total sleep time, sleepiness
MeSH terms
Aged, Central Nervous System Depressants, Double-Blind Method, Drug Therapy, Combination, Female, Humans, Sleep Initiation and Maintenance Disorders, Italy, Long-Term Care, Magnesium, Male, Melatonin, Nursing Homes, Quality of Life, Zinc, Dietary Supplements, Intention to Treat Analysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review